Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
The first families with LRRK2 related Parkinson’s disease (PD) were presented around 15 years ago and numerous papers have described the characteristics of the LRRK2 phenotype. The prevalence of autosomal dominant PD varies around the world mainly depending on local founder effects. The highest prev...
Main Author: | Jan O. Aasly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.634666/full |
Similar Items
-
Elevated Levels of Cerebrospinal Fluid α-Synuclein Oligomers in Healthy Asymptomatic LRRK2 Mutation Carriers
by: Jan eAasly, et al.
Published: (2014-09-01) -
Clinical and Imaging Markers of Prodromal Parkinson's Disease
by: Eldbjørg Hustad, et al.
Published: (2020-05-01) -
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
by: Nour K. Majbour, et al.
Published: (2020-05-01) -
Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson’s disease
by: Hsin Fen Chien, et al.
Published: (2014-05-01) -
LRRK2 G2019S, I2020T, R1441C GENE mutation analysis in patients with idiopathic Parkinsons in Turkey
by: Ahmet Adiguzel, et al.
Published: (2020-06-01)